X Facebook LinkedIn WhatsApp Press Releases Any 2024 2023 2022 2021 2020 2019 2018 2017 2016 (-) 2015 2014 2013 2012 2011 2010 2009 Reset 2015 May 28, 2015 arGEN-X Presents Preliminary Efficacy and Expanded Safety Data from Phase I Trial of ARGX-111 at ASCO May 20, 2015 arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions May 18, 2015 arGEN-X Awarded €1.5 Million IWT Grant to Advance the Application of NHance® Fc Modifications in Therapeutic Antibodies May 14, 2015 arGEN-X – First Quarter 2015 Financial Results and Business Update May 12, 2015 arGEN-X Announces Results of Annual General Meeting 2015 April 22, 2015 arGEN-X Announces Publication on Therapeutic Potential of ARGX-115 in Cancer Immunotherapy April 13, 2015 arGEN-x N.V. Announces Changes to the Board of Directors April 8, 2015 arGEN-X Opens Expansion Cohort in Phase 1b Study of ARGX-111 in Patients with MET Amplified Cancers March 31, 2015 arGEN-X Announces Annual General Meeting of Shareholders 13 May 2015 March 17, 2015 arGEN-X Reports Fourth Quarter Business Update And Full Year 2014 Financial Results March 12, 2015 arGEN-X to Present at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference March 10, 2015 arGEN-X to Host Conference Call & Webcast to Report Fourth Quarter Business Update and Full Year 2014 Financial Results on March 18, 2015 Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Next page Next › Last page Last »